Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 329,350 | 115,603 | 45,961 |
| Marketable Securities | 1,773 | 2,872 | 619 |
| Other current assets | 0 | 6,501 | 3,549 |
| TOTAL | $339,502 | $124,976 | $50,129 |
| Non-Current Assets | |||
| PPE Net | 17,969 | 22,836 | 8,345 |
| Other Non-Current Assets | 7,017 | 4,658 | 3,467 |
| TOTAL | $24,986 | $27,494 | $11,812 |
| Total Assets | $364,488 | $147,884 | $60,713 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 9,289 | 7,810 | 0 |
| Accrued Expenses | 6,702 | 6,498 | 2,675 |
| TOTAL | $18,470 | $14,308 | $2,675 |
| Non-Current Liabilities | |||
| Long Term Debt | 7,925 | 7,958 | 0 |
| Other Non-Current Liabilities | 3,156 | 215,714 | 101,116 |
| TOTAL | $11,081 | $223,672 | $101,116 |
| Total Liabilities | $29,551 | $237,980 | $103,791 |
| Shareholders' Equity | |||
| Common Shares | 34 | 10 | 10 |
| Retained earnings | -101,298 | -86,441 | -42,623 |
| Other shareholders' equity | -43 | -3,665 | -465 |
| TOTAL | $334,937 | $-90,096 | $-43,078 |
| Total Liabilities And Equity | $364,488 | $147,884 | $60,713 |